MLchartDataset catalogue

tyrosine kinase inhibitor IDRX-42

Term · Oncology and biomedicine · MLC-T-ONC-017378

An orally bioavailable small molecule inhibitor of an as of yet undisclosed tyrosine kinase, with potential antineoplastic activity. Upon oral administration, tyrosine kinase inhibitor IDRX-42 inhibits the activity of an as of yet undisclosed tyrosine kinase. This may result in antitumor activity in tumor cells in which the tyrosine kinase is upregulated or dysregulated.

Table 1. Record
IdentifierMLC-T-ONC-017378
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017378",
  "term": "tyrosine kinase inhibitor IDRX-42",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable small molecule inhibitor of an as of yet undisclosed tyrosine kinase, with potential antineoplastic activity. Upon oral administration, tyrosine kinase inhibitor IDRX-42 inhibits the activity of an as of yet undisclosed tyrosine kinase. This may result in antitumor activity in tumor cells in which the tyrosine kinase is upregulated or dysregulated.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tyrosine-kinase-inhibitor-idrx-42/"
}

Record 16,875 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.